Effectiveness of Denosumab in Postmenopausal Osteoporosis Treatment: A 1-yr Follow-up Single-center Study

• Asıl Yazarlar: Nihal Tezel (Yazar), Damla Cankurtaran (Yazar), Öznur Ecerkale (Yazar), Ece Ünlü Akyüz (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Galenos Yayinevi, 2021-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Objective:Denosumab is a humanized monoclonal antibody that targets the receptor activator of nuclear factor kappa-beta ligand. This study aimed to evaluate the effectiveness of denosumab, a new-generation drug, in treating postmenopausal osteoporosis (OP).Materials and Methods:The study included 15...